89 related articles for article (PubMed ID: 23965331)
1. The release and transdermal penetration of baclofen formulated in a poloxamer lecithin organogel.
Arnold JJ; Asbill S
Int J Pharm Compd; 2009; 13(6):569-71. PubMed ID: 23965331
[TBL] [Abstract][Full Text] [Related]
2. Effect of formulation pH on transdermal penetration of antiemetics formulated in poloxamer lecithin organogel.
Woodall R; Arnold JJ; McKay D; Asbill CS
Int J Pharm Compd; 2013; 17(3):247-53. PubMed ID: 24046940
[TBL] [Abstract][Full Text] [Related]
3. Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin.
Le UM; Baltzley S; AlGhananeem A
Int J Pharm Compd; 2018; 22(6):498-503. PubMed ID: 30384350
[TBL] [Abstract][Full Text] [Related]
4. Preparation and in vitro evaluation of a pluronic lecithin organogel containing ricinoleic acid for transdermal delivery.
Boddu SH; Bonam SP; Wei Y; Alexander K
Int J Pharm Compd; 2014; 18(3):256-61. PubMed ID: 25306775
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the percutaneous absorption of promethazine hydrochloride, in vitro, using the human ex vivo skin model.
Bassani AS; Banov D; Lehman PA
Int J Pharm Compd; 2008; 12(3):270-3. PubMed ID: 23969717
[TBL] [Abstract][Full Text] [Related]
6. Skin permeation and antinociception of topical gabapentin formulations.
Bryson E; Asbill S; Sweitzer S
Int J Pharm Compd; 2014; 18(6):504-11. PubMed ID: 25906628
[TBL] [Abstract][Full Text] [Related]
7. Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management.
Hong EJ; Sumanasekera W; Le UM
Int J Pharm Compd; 2022; 26(1):65-71. PubMed ID: 35081046
[TBL] [Abstract][Full Text] [Related]
8. Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations.
Bryson E; Hartman R; Arnold J; Gorman G; Sweitzer S; Asbill S
Int J Pharm Compd; 2015; 19(2):161-6. PubMed ID: 26685496
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Transdermal Drug Permeation as Modulated by Lipoderm and Pluronic Lecithin Organogel.
Zhang Q; Song Y; Page SW; Garg S
J Pharm Sci; 2018 Feb; 107(2):587-594. PubMed ID: 28935590
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the stability of promethazine hydrochloride in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
Peacock GF; Sauvageot J
Int J Pharm Compd; 2014; 18(4):345-7. PubMed ID: 25474864
[TBL] [Abstract][Full Text] [Related]
11. The use of Pluronic lecithin organogels in the transdermal delivery of drugs.
Bramwell BL; Williams LA
Int J Pharm Compd; 2012; 16(1):62-3. PubMed ID: 23050314
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the stability of fluoxetine in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
Peacock GF; Sauvageot J
Int J Pharm Compd; 2014; 18(3):253-5. PubMed ID: 25306774
[TBL] [Abstract][Full Text] [Related]
13. Pluronic lecithin organogel as a topical drug delivery system.
Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A
Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the stability of ketoprofen in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
Peacock GF; Sauvageot J; Addo RT
Int J Pharm Compd; 2014; 18(4):348-50. PubMed ID: 25474865
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of pluronic lecithin organogel containing fluocinolone acetonide.
Patel D; Patel V
Drug Dev Ind Pharm; 2021 Mar; 47(3):377-384. PubMed ID: 33493079
[TBL] [Abstract][Full Text] [Related]
16. Propolis organogel as a novel topical delivery system for treating wounds.
Balata G; El Nahas HM; Radwan S
Drug Deliv; 2014 Feb; 21(1):55-61. PubMed ID: 24295500
[TBL] [Abstract][Full Text] [Related]
17. In-vitro transcutaneous delivery of ketoprofen and polyunsaturated fatty acids from a pluronic lecithin organogel vehicle containing fish oil.
Richards H; Thomas CP; Bowen JL; Heard CM
J Pharm Pharmacol; 2006 Jul; 58(7):903-8. PubMed ID: 16805949
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the stability of acetaminophen in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
Peacock GF; Sauvageot J
Int J Pharm Compd; 2012; 16(5):428-30. PubMed ID: 23072202
[TBL] [Abstract][Full Text] [Related]
19. In vitro percutaneous absorption of ketoprofen and testosterone: comparison of pluronic lecithin organogel vs. pentravan cream.
Lehman PA; Raney SG
Int J Pharm Compd; 2012; 16(3):248-52. PubMed ID: 23050302
[TBL] [Abstract][Full Text] [Related]
20. Nifedipine in semi-solid formulations for topical use in peripheral vascular disease: preparation, characterization, and permeation assay.
Santis AK; de Freitas ZM; Ricci-Junior E; de Brito-Gitirana L; Fonseca LB; Santos EP
Drug Dev Ind Pharm; 2013 Jul; 39(7):1098-106. PubMed ID: 22901029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
